Dhingra, Kapil,Higgins, Brian,Kolinsky, Kenneth,Lee, Richard J.,Lestini, Brian,Packman, Kathryn E.,Su, Fei
申请号：
AU2011290818
公开号：
AU2011290818B2
申请日:
2011.08.16
申请国别(地区):
AU
年份:
2015
代理人:
摘要：
The present invention relates to a combination therapy of propane-1-sulfonic acid {3-[5-(4- chloro-phenyl)-1H-pyrrolo [2,3-b] pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide, or a pharmaceutically acceptable salt thereof, and an EGFR inhibitor for treating a patient suffering from a proliferative disorder, in particular a solid tumor, for example, colorectal cancer, melanoma, and thyroid cancer.
